Investigation on the current status of nutritional status and nutritional support in patients withgynecological malignant tumors during perioperative period
妇科恶性肿瘤患者围手术期营养状况和营养支持的现状调查

摘要

目的 研究分析妇科恶性肿瘤患者围手术期营养状况，并调查营养支持现状，以期能够为后续工作的开展提供一些帮助。方法 本次实验的时间区间为2020年2月至2021年3月，选定200例妇科恶性肿瘤患者作为研究对象。在本次实验中，研究人员应借助营养风险筛查表开展工作，对所选妇科恶性肿瘤患者进行筛查，记录所选患者围手术期营养状况，并调查所选患者营养支持的种类及方式，记录患者术后并发症出现情况。结果 本次实验所选200例妇科恶性肿瘤患者围手术期出现营养风险及营养不良的人数分别为130人及10人，占所选患者总人数的比例分别为65.00%及5.00%；所选200例患者中共计117人接受营养支持，占比为58.50%，117例患者均接受肠外营养支持，其中“全合一”输注的人数为10人，占比为8.55%，“单瓶输注”的人数为107人，占比为91.45%；所选200例患者中共计1人接受肠内营养支持，占比为0.50%；在130例存在营养风险的患者中，共计101人接受围手术期营养支持，占比为77.69%，无营养风险的70例患者中接受营养支持的人数为16人，占比为22.86%；NRS 2002≥3分的患者共计130人，其中出现术后并发症的人数为22人，占比为16.92%，NRS 2002＜3分的患者共计70人，仅有1例患者出现术后并发症，占比为1.43%。结论 妇科恶性肿瘤患者围手术期出现营养风险的概率较高，且现阶段营养支持不够科学合理，难以满足患者的需求，不利于患者的预后，医护人员应明确当前工作中存在的不足，并积极加以改进。

Abstract

Objective To study and analyze the nutritional status of patients with gynecological malignant tumors during the perioperative period, and to investigate the status of nutritional support, in order to provide some help for the follow-up work.
Methods The time interval of this experiment was from February 2020 to March 2021, and 200 patients with gynecological malignant tumors were selected as the research objects. In this experiment, researchers should use the nutritional risk screening form to screen the selected patients with gynecological malignant tumors, record the nutritional status of the selected patients during the perioperative period, and investigate the types and methods of nutritional support for the selected patients , to record the occurrence of postoperative complications in patients.
Results The number of perioperative nutritional risk and malnutrition in 200 gynecological malignant tumor patients selected in this experiment was 130 and 10, accounting for 65.00% and 5.00% of the total number of selected patients, respectively. A total of 117 of the 200 patients received nutritional support, accounting for 58.50%, and 117 patients received parenteral nutrition support, of which 10 received "all-in-one" infusion, accounting for 8.55%. The number of patients receiving "infusion" was 107, accounting for 91.45%; a total of 1 of the 200 selected patients received enteral nutrition support, accounting for 0.50%; among the 130 patients with nutritional risk, a total of 101 received Perioperative nutritional support accounted for 77.69%, and among the 70 patients without nutritional risk, 16 received nutritional support, accounting for 22.86%; a total of 130 patients had NRS 2002 score ≥ 3, of which postoperative The number of patients with complications was 22, accounting for 16.92%. There were 70 patients with NRS 2002 score < 3, and only 1 patient had postoperative complications, accounting for 1.43%.
Conclusion   Patients with gynecological malignant tumors have a high probability of nutritional risk in the perioperative period, and the nutritional support at this stage is not scientific and reasonable enough to meet the needs of patients, which is not conducive to the prognosis of patients. Actively improve.